Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...
Scientists at the University of Oxford, have identified how rare populations of abnormal cells drive the formation and ...
Clinical Trials Arena on MSN
Agomab’s ALK5 inhibitor to advance to Phase IIb in Crohn’s disease
Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...
Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...
STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- ...
UChicago Medicine has opened the first clinic of its kind in Chicago, and one of only a few nationwide, focused on preconception and pregnancy care for patients with Crohn’s disease and ulcerative ...
Thanks to COVID-era discussions, the 2023 coverage of a Delta passenger who had diarrhea in their seat (I cannot imagine), ...
Everyday Health on MSN
Crohn’s Disease and Night Sweats: Why They Happen and How to Manage Them
Learn about the connection between Crohn’s disease and night sweats, their possible causes, and get practical tips from ...
CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells ...
IN his early 20s, Liam Robertson felt “indestructible”. He was super fit, always out with friends and couldn’t have been ...
Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results